hubei minkang pharmaceutical (HBMK) Snapshot

hubei minkang pharmaceutical (HBMK) Details

Hubei Minkang Pharmaceutical Ltd offers research, development, manufacture, and marketing of traditional Chinese medicine (TCM) and chemical pharmaceuticals. The company produces 24 products, which include 7 prescription TCM products, 1 chemical or western-style medicine, and 16 over-the-counter (OTC) products in various product types, including pills, tablets, capsules, granules, oral liquids, syrups, mixtures and injections in approximately 400 formulations and dosages. Its primary products include Yinxing Damo Zhusheye, a chemical medication injectable for the prevention and treatment of coronary heart disease; An Ka Huangmin Jiaonang, a chemical medication that relieves cold and flu symptoms, including fever, headache, sore throat, and sneezing; Wei C Yinqiao Pian, an OTC pill used for relieving cold and flu symptoms, such as body aches, cough, fever, headache, and sore throat; Xumeian Capsule, a prescription TCM medication used for leucopenia; and Shuxin Koufouye, a prescription TCM oral medication for promoting blood circulation and relieving chest pain, shortness of breath, and fatigue associated with coronary heart disease. Hubei Minkang Pharmaceutical Ltd. sells its products through distributors in the People’s Republic of China, the United States, Japan, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Indonesia, and European countries. The company was founded in 2003 and is based in Yichang, China.

hubei minkang pharmaceutical (HBMK) Top Compensated Officers